AAAAAA

   
Results: 1-10 |
Results: 10
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma
Authors: Khorana, A Bunn, P McLaughlin, P Vose, J Stewart, C Czuczman, MS
Citation: A. Khorana et al., A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma, LEUK LYMPH, 41(1-2), 2001, pp. 77-87
Combination chemotherapy and rituximab
Authors: Czuczman, MS
Citation: Ms. Czuczman, Combination chemotherapy and rituximab, ANTI-CANC D, 12, 2001, pp. S15-S19
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
Authors: Czuczman, MS Grillo-Lopez, AJ McLaughlin, P White, CA Saleh, M Gordon, L LoBuglio, AF Rosenberg, J Alkuzweny, B Maloney, D
Citation: Ms. Czuczman et al., Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy, ANN ONCOL, 12(1), 2001, pp. 109-114
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecularweight heparin
Authors: Simon, M Hahn, T Ford, LA Anderson, B Swinnich, D Baer, MR Bambach, B Bernstein, SH Bernstein, ZP Czuczman, MS Slack, JL Wetzler, M Herzig, G Schriber, J McCarthy, PL
Citation: M. Simon et al., Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecularweight heparin, BONE MAR TR, 27(6), 2001, pp. 627-633
Viral complications - Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review
Authors: Khushalani, NI Bakri, FG Wentling, D Brown, K Mohr, A Anderson, B Keesler, C Ball, D Bernstein, ZP Bernstein, SH Czuczman, MS Segal, BH McCarthy, PL
Citation: Ni. Khushalani et al., Viral complications - Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review, BONE MAR TR, 27(10), 2001, pp. 1071-1073
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:Safety and efficacy of re-treatment
Authors: Davis, TA Grillo-Lopez, AJ White, CA McLaughlin, P Czuczman, MS Link, BK Maloney, DG Weaver, RL Rosenberg, J Levy, R
Citation: Ta. Davis et al., Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:Safety and efficacy of re-treatment, J CL ONCOL, 18(17), 2000, pp. 3135-3143
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
Authors: Czuczman, MS Grillo-Lopez, AJ White, CA Saleh, M Gordon, L LoBuglio, AF Jonas, C Klippenstein, D Dallaire, B Varns, C
Citation: Ms. Czuczman et al., Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy, J CL ONCOL, 17(1), 1999, pp. 268-276
CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma
Authors: Czuczman, MS
Citation: Ms. Czuczman, CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma, SEMIN ONCOL, 26(5), 1999, pp. 88-96
Rituximab - A viewpoint
Authors: Czuczman, MS
Citation: Ms. Czuczman, Rituximab - A viewpoint, DRUGS, 58(1), 1999, pp. 89-89
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364
Authors: Czuczman, MS Dodge, RK Stewart, CC Frankel, SR Davey, FR Powell, BL Szatrowski, TP Schiffer, CA Larson, RA Bloomfield, CD
Citation: Ms. Czuczman et al., Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364, BLOOD, 93(11), 1999, pp. 3931-3939
Risultati: 1-10 |